Recent Events & Catalysts
Novo Nordisk A/S (NVO) — real, dated facts. Not a claim about what caused any single day's price move.
News
Novo Nordisk Receives European Commission's Marketing Authorization For Wegovy Pill To Treat Adults With Obesity
Benzinga · today
How To Build A $50,000 Dividend Portfolio In Today's Market
SeekingAlpha · 2d ago
Novo Nordisk Shares Encouraging Long-Term Data From Hemophilia Program
Benzinga · 2d ago
Novo Nordisk's Wegovy Pill Escalates Eli Lilly Rivalry
SeekingAlpha · 6d ago
Novo Nordisk: Why I Don't Think The Story Is Broken
SeekingAlpha · 6d ago
Fundsmith Equity Fund: H1 2026 Sales
SeekingAlpha · 6d ago
If I Could Only Buy Two High-Yield Stocks In July 2026
SeekingAlpha · 7d ago
Novo Nordisk Loses Its Edge, And I'm Downgrading
SeekingAlpha · 8d ago
SEC Filings (90 days)
No 8-K filings in the last 90 days.
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.